Related Experiment Videos
HMR-3562. Aventis Pharma
1Infectious Disease Research, Abbott Laboratories, Abbott Park, IL 60064-3537, USA. zhenkun.ma@abbott.com
Abstract:
Aventis Pharma (formerly Hoechst Marion Roussel) is investigating the ketolides HMR-3562 and HMR-3787 as potential antibacterial agents. The compounds belong to a series of 2-fluoroketolides. They have exhibited potency against a range of gram-positive bacteria and other respiratory tract pathogens including Haemophilus influenzae in vitro and in vivo.
Insights
Aventis Pharma is developing novel 2-fluoroketolides, HMR-3562 and HMR-3787, as potent antibacterial agents. These compounds show effectiveness against gram-positive bacteria and respiratory pathogens like Haemophilus influenzae.
Area of Science:
- Pharmaceutical Science
- Microbiology
- Medicinal Chemistry
Background:
- Antibiotic resistance necessitates the development of novel antibacterial agents.
- Ketolides represent a promising class of antibiotics with a unique mechanism of action.
- Gram-positive bacteria and respiratory pathogens pose significant public health challenges.
Purpose of the Study:
- To investigate the antibacterial potential of novel 2-fluoroketolides, HMR-3562 and HMR-3787.
- To evaluate the in vitro and in vivo efficacy of these compounds against key pathogens.
Main Methods:
- Synthesis and characterization of 2-fluoroketolide compounds.
- In vitro susceptibility testing against a panel of gram-positive bacteria and respiratory pathogens.
- In vivo efficacy studies in relevant animal models.
Main Results:
- HMR-3562 and HMR-3787 demonstrated significant in vitro potency against various gram-positive bacteria.
- The compounds exhibited efficacy against respiratory tract pathogens, including Haemophilus influenzae.
- In vivo studies confirmed the antibacterial activity of the investigated ketolides.
Conclusions:
- Novel 2-fluoroketolides HMR-3562 and HMR-3787 show promise as potential antibacterial agents.
- These compounds warrant further investigation for the treatment of bacterial infections, particularly those caused by gram-positive bacteria and Haemophilus influenzae.